Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This update reflects a minor refresh of the page's content or layout as tracked by the site's revision system.
    Difference
    0.1%
    Check dated 2026-08-11T20:03:45.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Adds the disease focus Multiple myeloma and a related topics link (MedlinePlus Genetics) to the page to clarify the study context and provide a nearby resource. The page revision is updated from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-28T15:16:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The related topics section was altered by removing the header and the entries for 'Multiple myeloma' and 'MedlinePlus Genetics'.
    Difference
    0.2%
    Check dated 2026-07-21T12:08:44.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The related topics area now includes 'Multiple myeloma' and a 'MedlinePlus Genetics' link, and the revision tag was updated to v3.6.3 from v3.6.2.
    Difference
    0.2%
    Check dated 2026-07-07T00:45:55.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added 'Revision: v3.6.2' in the page footer and removed specific related topics entries (e.g., 'Multiple myeloma' and 'MedlinePlus Genetics'), along with deleting the older 'Revision: v3.6.0' text.
    Difference
    0.2%
    Check dated 2026-06-29T17:48:05.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The page now includes additional related topic entries, specifically listing Multiple myeloma and linking to MedlinePlus Genetics under the related topics section, expanding access to disease information within the study context.
    Difference
    0.2%
    Check dated 2026-06-22T12:42:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.